Fresenius Medical Care AG & Co. KGaA (FMS)
Fresenius Medical Care AG & Co. KGaA at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Fresenius Medical Care AG & Co. KGaA (FMS) is a Medical - Care Facilities company based in DE with a market capitalization of $11.6B. Revenue grew 1.5% year-over-year and the company generated $1.7B in free cash flow. This page tracks FMS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
DE · 112.04K employees · IPO Sep 17, 1996
Valuation
Valuation & price
$21.63 · as of May 26, 2026 · -22.6% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$11.6B
Market cap
1.5%
Revenue growth (YoY)
25.6%
Gross margin
$1.7B
Free cash flow (USD)
$9.2B
Net debt
-0.9%
Share dilution
3/6
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 6-K filed May 5, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Fresenius Medical Care AG & Co. KGaA's market cap?
Fresenius Medical Care AG & Co. KGaA (FMS) has a market capitalization of $11.6B.
What is FMS's P/E ratio?
A meaningful P/E ratio is not available for FMS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
Are insiders buying FMS stock?
SEC Form 4 filings show no open-market insider buys at Fresenius Medical Care AG & Co. KGaA in the last 90 days (0 sells).
Same arena
Related companies in Medical - Care Facilities
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.